July 6, 2020Future Cardiology

Diagnostic work-up and Therapeutic Implications in MINOCA: Need for a Personalized Approach

View Full Paper

Ask AI

Bookmark

Why the study?

MINOCA carries a non-negligible risk of mortality and morbidity, but prospective clinical trials are lacking and treatments for obstructive MI cannot be assumed to translate.

Design

Commentary

Authors

MBMarco Giuseppe Del Buono RMRocco Antonio Montone GIGiulia Iannaccone

Discussion

Member takes

Overview

MINOCA carries notable long-term risks; leaves open evidence-based management pending dedicated prospective trials.

Structured PICO

Population

Patients with Myocardial infarction with non-obstructive coronary artery (MINOCA) disease

Intervention

Multimodality assessment and personalized treatment

Highlights the need for multimodality imaging and personalized therapeutic approaches in patients with MINOCA, given its non-negligible risk of adverse outcomes.

Cite This Study

Buono et al. (2020) studied this question.

synapsesocial.com/papers/6a712bcf2163a0a01bc557b8 https://doi.org/10.2217/fca-2020-0052

View Full Paper

Ask AI

Bookmark

July 6, 2020Future Cardiology

Diagnostic work-up and Therapeutic Implications in MINOCA: Need for a Personalized Approach

View Full Paper

Ask AI

Bookmark

Why the study?

MINOCA carries a non-negligible risk of mortality and morbidity, but prospective clinical trials are lacking and treatments for obstructive MI cannot be assumed to translate.

Design

Commentary

Authors

MBMarco Giuseppe Del Buono RMRocco Antonio Montone GIGiulia Iannaccone

Discussion

Member takes

Overview

MINOCA carries notable long-term risks; leaves open evidence-based management pending dedicated prospective trials.

Structured PICO

Population

Patients with Myocardial infarction with non-obstructive coronary artery (MINOCA) disease

Intervention

Multimodality assessment and personalized treatment

Highlights the need for multimodality imaging and personalized therapeutic approaches in patients with MINOCA, given its non-negligible risk of adverse outcomes.

Cite This Study

Buono et al. (2020) studied this question.

synapsesocial.com/papers/6a712bcf2163a0a01bc557b8 https://doi.org/10.2217/fca-2020-0052

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark